NATRILIX

This brand name is authorized in Australia, Brazil, Ecuador, Finland, Germany, Hong Kong SAR China, Ireland, Italy, Malta, Mexico, Nigeria, Singapore, South Africa, UK.

Active ingredients

The drug NATRILIX contains one active pharmaceutical ingredient (API):

1	Indapamide UNII F089I0511L - INDAPAMIDE
	Indapamide is a sulfonamide derivative with an indole ring, pharmacologically related to thiazide diuretics, which acts by inhibiting the reabsorption of sodium in the cortical dilution segment. It increases the urinary excretion of sodium and chlorides and, to a lesser extent, the excretion of potassium and magnesium, thereby increasing urine output and having an antihypertensive action.
	Read more about Indapamide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NATRILIX Prolonged-release tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03BA11	Indapamide	C Cardiovascular system → C03 Diuretics → C03B Low-ceiling diuretics, excl. thiazides → C03BA Sulfonamides, plain
Discover more medicines within C03BA11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	2436F, 8532C
BR	Câmara de Regulação do Mercado de Medicamentos	531301001113318, 531301002111319, 531301101118311, 531301102114311, 531313050005803, 531315120007303, 531315120007403
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02410239, 02520005, 02520011
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	21.759-1-05-06
FI	Lääkealan turvallisuus- ja kehittämiskeskus	006068, 096685, 123505, 154518
GB	Medicines & Healthcare Products Regulatory Agency	13572, 13603, 13604, 143293, 186029
HK	Department of Health Drug Office	41343
IE	Health Products Regulatory Authority	67363, 67370
IT	Agenzia del Farmaco	024032031
MT	Medicines Authority	MA066/00901, PI1438/05201A, PI521/04401B, PI908/02001A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	133M2003
NG	Registered Drug Product Database	04-8509
Switch country to Nigeria in order to find specific presentations of NATRILIX
SG	Health Sciences Authority	09074P
ZA	Health Products Regulatory Authority	31/7.1/0166